PureTech Health Statistics
Total Valuation
PureTech Health has a market cap or net worth of $369.43 million. The enterprise value is $196.06 million.
Important Dates
The last earnings date was Thursday, August 28, 2025, before market open.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PureTech Health has 240.25 million shares outstanding. The number of shares has decreased by -11.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 240.25M |
| Shares Change (YoY) | -11.33% |
| Shares Change (QoQ) | -1.00% |
| Owned by Insiders (%) | 3.52% |
| Owned by Institutions (%) | 75.64% |
| Float | 167.98M |
Valuation Ratios
The trailing PE ratio is 7.29.
| PE Ratio | 7.29 |
| Forward PE | n/a |
| PS Ratio | 57.81 |
| Forward PS | n/a |
| PB Ratio | 1.00 |
| P/TBV Ratio | 0.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 3.87 |
| EV / Sales | 30.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.49, with a Debt / Equity ratio of 0.44.
| Current Ratio | 8.49 |
| Quick Ratio | 8.35 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.44% and return on invested capital (ROIC) is -14.92%.
| Return on Equity (ROE) | 9.44% |
| Return on Assets (ROA) | -12.95% |
| Return on Invested Capital (ROIC) | -14.92% |
| Return on Capital Employed (ROCE) | -22.90% |
| Revenue Per Employee | $114,125 |
| Profits Per Employee | $904,964 |
| Employee Count | 56 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PureTech Health has paid $3.06 million in taxes.
| Income Tax | 3.06M |
| Effective Tax Rate | 8.76% |
Stock Price Statistics
The stock price has decreased by -19.72% in the last 52 weeks. The beta is 0.82, so PureTech Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -19.72% |
| 50-Day Moving Average | 17.95 |
| 200-Day Moving Average | 18.30 |
| Relative Strength Index (RSI) | 36.59 |
| Average Volume (20 Days) | 5,041 |
Short Selling Information
| Short Interest | 6,111 |
| Short Previous Month | 4,899 |
| Short % of Shares Out | 0.03% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, PureTech Health had revenue of $6.39 million and earned $50.68 million in profits. Earnings per share was $0.20.
| Revenue | 6.39M |
| Gross Profit | -48.81M |
| Operating Income | -117.40M |
| Pretax Income | -35.17M |
| Net Income | 50.68M |
| EBITDA | -115.72M |
| EBIT | -117.40M |
| Earnings Per Share (EPS) | $0.20 |
Full Income StatementBalance Sheet
The company has $331.28 million in cash and $163.57 million in debt, giving a net cash position of $167.71 million or $0.70 per share.
| Cash & Cash Equivalents | 331.28M |
| Total Debt | 163.57M |
| Net Cash | 167.71M |
| Net Cash Per Share | $0.70 |
| Equity (Book Value) | 369.03M |
| Book Value Per Share | 1.56 |
| Working Capital | 303.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$100.30 million and capital expenditures -$11,000, giving a free cash flow of -$100.31 million.
| Operating Cash Flow | -100.30M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -100.31M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,837.01% |
| Pretax Margin | 546.82% |
| Profit Margin | 792.96% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PureTech Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.33% |
| Shareholder Yield | 11.33% |
| Earnings Yield | 13.72% |
| FCF Yield | -27.15% |
Analyst Forecast
The average price target for PureTech Health is $45.00, which is 190.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $45.00 |
| Price Target Difference | 190.14% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PureTech Health has an Altman Z-Score of 1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 4 |
